Provided by Tiger Trade Technology Pte. Ltd.

FibroGen

9.71
0.0000
Volume:- -
Turnover:323.61K
Market Cap:39.28M
PE:0.18
High:9.71
Open:9.71
Low:9.71
Close:9.71
52wk High:21.94
52wk Low:4.85
Shares:4.05M
Float Shares:3.62M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):53.38
EPS(LYR):-11.8895
ROE:-1015.79%
ROA:-18.42%
PB:-2.31
PE(LYR):-0.82

Loading ...

FibroGen Price Target Maintained With a $43.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 24, 2025

FibroGen’s Strategic and Financial Advancements: A Positive Outlook on FG-3246 and Roxadustat

TIPRANKS
·
Sep 24, 2025

BRIEF-FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer

Reuters
·
Sep 24, 2025

FibroGen Launches Phase 2 Trial of FG-3246 for mCRPC, Evaluates FG-3180 as Companion PET Imaging Biomarker

Reuters
·
Sep 24, 2025

FibroGen Inc - Interim Analysis of Trial Expected in 2H 2026

THOMSON REUTERS
·
Sep 24, 2025

FibroGen Inc - Topline Results of FG-3246 in Combination With Enzalutamide in Patients With Mcrpc Enzalutamide Expected Q4 2025

THOMSON REUTERS
·
Sep 24, 2025

FGEN Enhances Share Capital Management with Treasury Share Purchase

TIPRANKS
·
Sep 23, 2025

SEC charges former FibroGen CMO for false claims on clinical trial results

TIPRANKS
·
Sep 11, 2025

FibroGen Inc. Releases Proforma Financials Following $220 Million Sale of FibroGen China to AstraZeneca

Reuters
·
Sep 06, 2025

Press Release: FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million

Dow Jones
·
Sep 02, 2025

FibroGen Inc. Gains Approval from China for Sale of FibroGen China to AstraZeneca, Closing Expected in Q3 2025

Reuters
·
Aug 18, 2025

FibroGen Inc - Sale of FibroGen China on Track to Close in 3Q 2025

THOMSON REUTERS
·
Aug 18, 2025

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

THOMSON REUTERS
·
Aug 18, 2025

FibroGen Inc. Reduces Cash Balance Requirement with Fourth Amendment to Financing Agreement

Reuters
·
Aug 14, 2025

FibroGen Shares up 14.8% After Q2 Results, Cash Flow Update

THOMSON REUTERS
·
Aug 12, 2025

Top Premarket Gainers

MT Newswires Live
·
Aug 12, 2025

FibroGen Q2 EPS $(1.88) Beats $(2.25) Estimate, Sales $1.35M Miss $2.63M Estimate

Benzinga
·
Aug 12, 2025

FibroGen Inc. Reports Q2 2025 Financial Results; Sale of FibroGen China to Boost Cash Runway into 2028

Reuters
·
Aug 12, 2025

FibroGen Inc: Upon Close of Sale of FibroGen China, Cash Runway Extended Into 2028

THOMSON REUTERS
·
Aug 12, 2025

FibroGen Inc - Sale of FibroGen China to AstraZeneca Expected to Be for $210 Mln

THOMSON REUTERS
·
Aug 12, 2025